Published in J Cell Biochem on October 01, 1990
Matuzumab binding to EGFR prevents the conformational rearrangement required for dimerization. Cancer Cell (2008) 2.21
Interaction of antibodies with ErbB receptor extracellular regions. Exp Cell Res (2008) 1.13
Regulation of Bcl-xL expression in human keratinocytes by cell-substratum adhesion and the epidermal growth factor receptor. Proc Natl Acad Sci U S A (1997) 0.93
Antitumor effect of MAb EMD 55900 depends on EGF-R expression and histopathology. Neoplasia (2002) 0.87
Interrupting autocrine ligand-receptor binding: comparison between receptor blockers and ligand decoys. Biophys J (1992) 0.87
Immunocytochemical expression of growth factors by odontogenic jaw cysts. Mol Pathol (1997) 0.82
EGFR Intron Recombination in Human Gliomas: Inappropriate Diversion of V(D)J Recombination? Curr Genomics (2007) 0.80
A 34-kd protein with strong homology to ras-like proteins inhibits epidermal growth factor activity. Am J Pathol (1993) 0.75
Dose-dependent access of murine anti-epidermal growth factor receptor monoclonal antibody to tumor cells in patients with advanced laryngeal and hypopharyngeal carcinoma. Eur Arch Otorhinolaryngol (1995) 0.75
Phage transfer: a new player turns up in cholera infection. Science (1996) 13.90
Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet (1979) 7.28
Solvents degreasing and the Montreal protocol. Occup Med (Lond) (1996) 4.82
A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology (1989) 4.27
Study of antibodies against human melanoma produced by somatic cell hybrids. Proc Natl Acad Sci U S A (1978) 4.24
Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression. Cancer Res (1990) 4.22
Specific antigen in serum of patients with colon carcinoma. Science (1981) 3.68
Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. Proc Natl Acad Sci U S A (1979) 3.46
Practice guideline for the ED management of falls in community-dwelling elderly persons. Kaiser Permanente Medical Group. Ann Emerg Med (1997) 3.40
The separation of different cell classes from lymphoid organs. V. Simple procedures for the removal of cell debris. Damaged cells and erythroid cells from lymphoid cell suspensions. J Immunol Methods (1972) 3.08
Surgeons and the risks of contamination during operations. J R Soc Med (1991) 2.82
A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease. N Engl J Med (1989) 2.71
N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res (2001) 2.47
E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am J Pathol (2000) 2.36
Cheap, accurate and rapid allele frequency estimation of single nucleotide polymorphisms by primer extension and DHPLC in DNA pools. Hum Genet (2000) 2.26
A full genome scan for late onset Alzheimer's disease. Hum Mol Genet (1999) 2.26
Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients. J Exp Med (1993) 2.24
Human melanoma progression in skin reconstructs : biological significance of bFGF. Am J Pathol (2000) 2.23
Gastrointestinal cancer-associated antigen in immunoperoxidase assay. Cancer Res (1982) 2.21
CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations. Oncogene (2008) 2.19
Melanoma cell lines from different stages of progression and their biological and molecular analyses. Melanoma Res (1997) 2.11
Nobel Prizes. Newspaper backs down over allegations of impropriety. Science (1995) 2.03
Yeast genome sequence ferments new research. Science (1996) 2.01
An objective scoring system for laparoscopic cholecystectomy. J Am Coll Surg (1999) 1.89
Increased acid-sensing ion channel ASIC-3 in inflamed human intestine. Eur J Gastroenterol Hepatol (2001) 1.87
Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine. Cancer Res (1994) 1.86
Characteristics of cultured human melanocytes isolated from different stages of tumor progression. Cancer Res (1985) 1.85
Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor. EMBO J (1989) 1.84
Molecules stimulating early red cell, granulocyte, macrophage, and megakaryocyte precursors in culture: similarity in size, hydrophobicity, and charge. J Cell Physiol Suppl (1982) 1.77
Monoclonal antibody detection of a circulating tumor-associated antigen. I. Presence of antigen in sera of patients with colorectal, gastric, and pancreatic carcinoma. J Clin Immunol (1982) 1.76
Insulin-like growth factor-1 induces survival and growth of biologically early melanoma cells through both the mitogen-activated protein kinase and beta-catenin pathways. Cancer Res (2001) 1.75
Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies. Proc Natl Acad Sci U S A (1984) 1.74
Expression of insulin growth factor-1 splice variants and structural genes in rabbit skeletal muscle induced by stretch and stimulation. J Physiol (1999) 1.74
Chronic norovirus infection in pediatric hematopoietic stem cell transplant recipients: a cause of prolonged intestinal failure requiring intensive nutritional support. Pediatr Transplant (2011) 1.72
The separation of different cell classes from lymphoid organs. IV. The separation of lymphocytes from phagocytes on glass bead columns, and its effect on subpopulations of lymphocytes and antibody-forming cells. J Cell Biol (1971) 1.72
Membrane receptors of mouse leukocytes. II. Sequential expression of membrane receptors and phagocytic capacity during leukocyte differentiation. J Exp Med (1978) 1.69
Polymer-fume fever: not so benign. J Occup Med (1974) 1.69
Mechanism for elimination of a tumor suppressor: aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma. Proc Natl Acad Sci U S A (1999) 1.68
In vitro colony formation by normal and leukemic human hematopoietic cells: characterization of the colony-forming cells. J Natl Cancer Inst (1973) 1.65
Agar culture studies in 127 cases of untreated acute leukemia: the prognostic value of reclassification of leukemia according to in vitro growth characteristics. Blood (1974) 1.64
Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB. Proc Natl Acad Sci U S A (1993) 1.63
Biology of tumor progression in human melanocytes. Lab Invest (1987) 1.61
Differentiation of mouse bone marrow precursor cells into neutrophil granulocytes by an activity separation from WEHI-3 cell-conditioned medium. Differentiation (1978) 1.61
Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma development. Oncogene (2001) 1.59
Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma. Eur J Immunol (1979) 1.59
Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels. Br J Cancer (2007) 1.57
Evaluation of a point-of-care blood test for identification of Ebola virus disease at Ebola holding units, Western Area, Sierra Leone, January to February 2015. Euro Surveill (2015) 1.56
Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. Proc Natl Acad Sci U S A (1991) 1.54
Raf-1 is a potential substrate for mitogen-activated protein kinase in vivo. Biochem J (1991) 1.54
Human melanoma cell lines of primary and metastatic origin express the genes encoding the chains of platelet-derived growth factor (PDGF) and produce a PDGF-like growth factor. Proc Natl Acad Sci U S A (1986) 1.54
Non-invasive detection of hypoglycaemia using a novel, fully biocompatible and patient friendly alarm system. BMJ (2001) 1.53
First Dolly, now headless tadpoles. Science (1997) 1.51
Adenoviral gene transfer of beta3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma. Am J Pathol (1998) 1.50
Combined targeting of MAPK and AKT signalling pathways is a promising strategy for melanoma treatment. Br J Dermatol (2007) 1.49
Relationship between myocardial counts and patient weight: adjusting the injected activity in myocardial perfusion scans. Nucl Med Commun (2003) 1.48
Clinical trial: once-daily mesalamine granules for maintenance of remission of ulcerative colitis - a 6-month placebo-controlled trial. Aliment Pharmacol Ther (2010) 1.47
Induction of antibody-dependent and nonspecific tumor killing in human monocytic leukemia cells by nonlymphocyte factors and phorbol ester. Cell Immunol (1982) 1.44
Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int J Cancer (1994) 1.44
Chromatin binding of epidermal growth factor, nerve growth factor, and platelet-derived growth factor in cells bearing the appropriate surface receptors. Proc Natl Acad Sci U S A (1986) 1.44
Genetic studies on chromosome 12 in late-onset Alzheimer disease. JAMA (1998) 1.44
Cadherin repertoire determines partner-specific gap junctional communication during melanoma progression. J Cell Sci (2000) 1.44
Unique protein database imperiled. Science (1996) 1.43
Functional expression of Shaker K+ channels in a baculovirus-infected insect cell line. Neuron (1990) 1.42
Local impact of the English arm of the UK Bowel Cancer Screening Pilot study. Br J Surg (2008) 1.42
Interleukin-8 overexpression is present in pyoderma gangrenosum ulcers and leads to ulcer formation in human skin xenografts. Lab Invest (2000) 1.42
Human/severe combined immunodeficient mouse chimeras. An experimental in vivo model system to study the regulation of human endothelial cell-leukocyte adhesion molecules. J Clin Invest (1993) 1.42
Can self-reported height and weight be relied upon? Occup Med (Lond) (2011) 1.42
Drug companies decline to cooperate. Science (1997) 1.40
Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling. Cancer Res (2001) 1.40
Growth and invasion of human melanomas in human skin grafted to immunodeficient mice. Am J Pathol (1993) 1.39
Care of long-term central venous catheters. Br J Hosp Med (1994) 1.39
Tobacco funding debate smolders. Science (1996) 1.39
A secure retraction technique for exposing the internal mammary vessels. Ann R Coll Surg Engl (2013) 1.39
Fractal geometry gets the measure of life's scales. Science (1997) 1.39
Britain hunts down CJD epidemic in removed appendixes. Science (1998) 1.38
Isolation and functional characterization of the A32 melanoma-associated antigen. Cancer Res (1994) 1.38
What are the causes of a perforated nasal septum? Occup Med (Lond) (2000) 1.38
Genotyping single nucleotide polymorphisms by primer extension and high performance liquid chromatography. Hum Genet (1999) 1.37
Regulation of megakaryopoiesis in long-term murine bone marrow cultures. Blood (1978) 1.37
Efficient selection of human tumor growth-inhibiting monoclonal antibodies. J Immunol Methods (1984) 1.37
Undifferentiated keratinocytes control growth, morphology, and antigen expression of normal melanocytes through cell-cell contact. Lab Invest (1993) 1.36
Matrix immobilization enhances the tissue repair activity of growth factor gene therapy vectors. Hum Gene Ther (2001) 1.36
Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes. J Invest Dermatol (1991) 1.35
Karyotypic evolution in human malignant melanoma. Cancer Genet Cytogenet (1986) 1.34
In vitro colony formation by normal and leukemic human hematopoietic cells: interaction between colony-forming and colony-stimulating cells. J Natl Cancer Inst (1973) 1.34
Shifts in cadherin profiles between human normal melanocytes and melanomas. J Investig Dermatol Symp Proc (1996) 1.33
Cultural phenomena and the research enterprise: toward a culturally anchored methodology. Am J Community Psychol (1993) 1.33
Absence of BRAF mutations in UV-protected mucosal melanomas. J Med Genet (2004) 1.32
Purification and characterisation of the in vitro colony forming cell in monkey hemopoietic tissue. J Cell Physiol (1972) 1.32
Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells. J Immunol (2001) 1.31
Human megakaryocytes. I. Characterization of the membrane and cytoplasmic components of isolated marrow megakaryocytes. J Exp Med (1979) 1.31
Monoclonal antibody detection of a circulating tumor-associated antigen. II. A longitudinal evaluation of patients with colorectal cancer. J Clin Immunol (1982) 1.31
Primary melanoma cells of the vertical growth phase: similarities to metastatic cells. J Natl Cancer Inst (1985) 1.30
Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells. Cancer Res (1994) 1.29
A simple method for analyzing microsatellite allele image patterns generated from DNA pools and its application to allelic association studies. Am J Hum Genet (1998) 1.29
Binding of an antagonistic monoclonal antibody to an intact and fragmented EGF-receptor polypeptide. Arch Biochem Biophys (1987) 1.29